Endovascular Treatment of Thoracic Aortic Disease

计划入组 170 人 · 首次发布于 2007 年 12 月 31 日

Multidisciplinary Analysis by Morphological and Mechanical Evaluation of the Aortic Wall in Patients Undergoing Cardiac Surgery.

计划入组 250 人 · 首次发布于 2026 年 2 月 19 日

Prospective Evaluation of Physician Modified Endografts for Aortic Disease

计划入组 20 人 · 首次发布于 2026 年 5 月 28 日

liver disease program

siRNA therapeutics for ocular disease/dermatological disease (Phio Pharmaceuticals)

undisclosed drug (fibrotic liver disease/NASH), Engitix/Takeda

THUBRIKAR AORTIC VALVE INC

United States

Artivion

United States

Rare Disease Research, LLC

FDA Approves NEXUS Aortic Arch Stent Graft System for Minimally Invasive Treatment of Complex Aortic Disease

Endospan's NEXUS Aortic Arch Stent-Graft Shows Promising 30-Day Results in FDA TRIOMPHE Trial

Endospan Completes Enrollment in TRIOMPHE Trial for NEXUS Aortic Arch Stent Graft